Pharmaceuticals Global Group of Eight (G8) Industry Guide 2020-2029

MarketLine
380 Pages - MLINE36017
$1,495.00

Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The G8 countries contributed $9,23,903.9 million in 2024 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 4% between 2020 and 2024. The G8 countries are expected to reach a value of $11,50,034.3 million in 2029, with a CAGR of 4.5% over the 2024-29 period.
- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $5,69,333.8 million in 2024. This was followed by Germany and Japan, with a value of $85,905.4 and $69,384.6 million, respectively.
- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $7,09,520.1 million in 2016, followed by Germany and Japan with expected values of $1,07,651.0 and $82,456.9 million, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the G8 pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to Buy

- What was the size of the G8 pharmaceuticals market by value in 2024?
- What will be the size of the G8 pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the G8 pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up the G8 pharmaceuticals market?

'

Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Pharmaceuticals in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
14 Macroeconomic Indicators
14.1. Country data
15 Pharmaceuticals in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
16 Macroeconomic Indicators
16.1. Country data
17 Pharmaceuticals in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
18 Macroeconomic Indicators
18.1. Country data
19 Company Profiles
19.1. Johnson & Johnson
19.2. Merck & Co Inc
19.3. AbbVie Inc
19.4. Pfizer Inc
19.5. Sinopharm Group Co Ltd
19.6. Shanghai Pharmaceuticals Holding Co Ltd
19.7. CSPC Pharmaceutical Group Ltd
19.8. Takeda Pharmaceutical Co Ltd
19.9. Novartis AG
19.10. AstraZeneca Plc
19.11. GSK plc
19.12. F. Hoffmann-La Roche Ltd
19.13. Sanofi
19.14. Laboratoires Pierre Fabre SA
19.15. Les Laboratoires Servier SAS
19.16. Ipsen SA
19.17. Bayer AG
19.18. Boehringer Ingelheim International GmbH
19.19. Fresenius Medical Care AG & Co KGaA
19.20. Merck KGaA
19.21. CSL Ltd
19.22. Ramsay Health Care Ltd
19.23. Mayne Pharma Group Ltd
19.24. Ache Laboratorios Farmaceuticos SA
19.25. EMS SA
19.26. Hypera SA
19.27. Eurofarma Laboratorios SA
19.28. Apotex Inc
19.29. Bausch Health Companies Inc
19.30. Jiangsu Hengrui Pharmaceuticals Co Ltd
19.31. Sun Pharmaceutical Industries Ltd
19.32. Lupin Ltd
19.33. Cipla Ltd
19.34. Dr. Reddy's Laboratories Ltd
19.35. PT Kimia Farma Tbk
19.36. PT Kalbe Farma Tbk
19.37. PT Tempo Scan Pacific Tbk
19.38. A. Menarini Industrie Farmaceutiche Riunite Srl
19.39. Recordati SpA
19.40. Chiesi Farmaceutici SpA
19.41. Astellas Pharma Inc
19.42. Daiichi Sankyo Co Ltd
19.43. Otsuka Holdings Co Ltd
19.44. Genomma Lab Internacional SAB de CV
19.45. Pharmstandard
19.46. Binnopharm Group
19.47. OTC Pharma International BV
19.48. H. Lundbeck AS
19.49. Novo Nordisk AS
19.50. Aspen Pharmacare Holdings Ltd
19.51. Adcock Ingram Holdings Ltd
19.52. Chong Kun Dang Pharmaceutical Corp.
19.53. Hanmi Pharmaceuticals Co Ltd
19.54. Celltrion Inc
19.55. Yuhan Corp
19.56. Almirall SAS
19.57. Grifols SA
19.58. Laboratorios Farmaceuticos Rovi SA
19.59. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
19.60. Deva Holding AS
20 Appendix
20.1. Methodology
20.2. About MarketLine

List of Tables
Table 1: G8 pharmaceuticals industry, revenue($m), 2020-29
Table 2: G8 pharmaceuticals industry, revenue by country ($m), 2020-24
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($m), 2024-29
Table 4: Canada pharmaceuticals market value: $ million, 2019-24
Table 5: Canada pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 6: Canada pharmaceuticals market category segmentation: $ million, 2019-24
Table 7: Canada pharmaceuticals market geography segmentation: $ million, 2024
Table 8: Canada pharmaceuticals market value forecast: $ million, 2024-29
Table 9: Canada Size of Population (Million), 2020-24
Table 10: Canada Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 11: Canada GDP (Current Prices, $ Billion), 2020-24
Table 12: Canada Inflation, 2020-24
Table 13: Canada Consumer Price Index (Absolute), 2020-24
Table 14: Canada Exchange Rate, 2019-24
Table 15: France pharmaceuticals market value: $ million, 2019-24
Table 16: France pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 17: France pharmaceuticals market category segmentation: $ million, 2019-24
Table 18: France pharmaceuticals market geography segmentation: $ million, 2024
Table 19: France pharmaceuticals market value forecast: $ million, 2024-29
Table 20: France Size of Population (Million), 2020-24
Table 21: France Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: France GDP (Current Prices, $ Billion), 2020-24
Table 23: France Inflation, 2020-24
Table 24: France Consumer Price Index (Absolute), 2020-24
Table 25: France Exchange Rate, 2019-24
Table 26: Germany pharmaceuticals market value: $ million, 2019-24
Table 27: Germany pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 28: Germany pharmaceuticals market category segmentation: $ million, 2019-24
Table 29: Germany pharmaceuticals market geography segmentation: $ million, 2024
Table 30: Germany pharmaceuticals market value forecast: $ million, 2024-29
Table 31: Germany Size of Population (Million), 2020-24
Table 32: Germany Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 33: Germany GDP (Current Prices, $ Billion), 2020-24
Table 34: Germany Inflation, 2020-24
Table 35: Germany Consumer Price Index (Absolute), 2020-24
Table 36: Germany Exchange Rate, 2019-24
Table 37: Italy pharmaceuticals market value: $ million, 2019-24
Table 38: Italy pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 39: Italy pharmaceuticals market category segmentation: $ million, 2019-24
Table 40: Italy pharmaceuticals market geography segmentation: $ million, 2024
Table 41: Italy pharmaceuticals market value forecast: $ million, 2024-29
Table 42: Italy Size of Population (Million), 2020-24
Table 43: Italy Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 44: Italy GDP (Current Prices, $ Billion), 2020-24
Table 45: Italy Inflation, 2020-24
Table 46: Italy Consumer Price Index (Absolute), 2020-24
Table 47: Italy Exchange Rate, 2019-24
Table 48: Japan pharmaceuticals market value: $ million, 2019-24
Table 49: Japan pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 50: Japan pharmaceuticals market category segmentation: $ million, 2019-24
Table 51: Japan pharmaceuticals market geography segmentation: $ million, 2024
Table 52: Japan pharmaceuticals market value forecast: $ million, 2024-29
Table 53: Japan Size of Population (Million), 2020-24
Table 54: Japan Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 55: Japan GDP (Current Prices, $ Billion), 2020-24
Table 56: Japan Inflation, 2020-24
Table 57: Japan Consumer Price Index (Absolute), 2020-24
Table 58: Japan Exchange Rate, 2019-24
Table 59: Russia pharmaceuticals market value: $ million, 2019-24
Table 60: Russia pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 61: Russia pharmaceuticals market category segmentation: $ million, 2019-24
Table 62: Russia pharmaceuticals market geography segmentation: $ million, 2024
Table 63: Russia pharmaceuticals market value forecast: $ million, 2024-29
Table 64: Russia Size of Population (Million), 2020-24
Table 65: Russia Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 66: Russia GDP (Current Prices, $ Billion), 2020-24
Table 67: Russia Inflation, 2020-24
Table 68: Russia Consumer Price Index (Absolute), 2020-24
Table 69: Russia Exchange Rate, 2019-24
Table 70: United Kingdom pharmaceuticals market value: $ million, 2019-24
Table 71: United Kingdom pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 72: United Kingdom pharmaceuticals market category segmentation: $ million, 2019-24
Table 73: United Kingdom pharmaceuticals market geography segmentation: $ million, 2024
Table 74: United Kingdom pharmaceuticals market value forecast: $ million, 2024-29
Table 75: United Kingdom Size of Population (Million), 2020-24
Table 76: United Kingdom Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 77: United Kingdom GDP (Current Prices, $ Billion), 2020-24
Table 78: United Kingdom Inflation, 2020-24
Table 79: United Kingdom Consumer Price Index (Absolute), 2020-24
Table 80: United Kingdom Exchange Rate, 2019-24
Table 81: United States pharmaceuticals market value: $ million, 2019-24
Table 82: United States pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 83: United States pharmaceuticals market category segmentation: $ million, 2019-24
Table 84: United States pharmaceuticals market geography segmentation: $ million, 2024
Table 85: United States pharmaceuticals market value forecast: $ million, 2024-29
Table 86: United States Size of Population (Million), 2020-24
Table 87: United States Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 88: United States GDP (Current Prices, $ Billion), 2020-24
Table 89: United States Inflation, 2020-24
Table 90: United States Consumer Price Index (Absolute), 2020-24
Table 91: United States Exchange Rate, 2019-24

List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($m), 2020-29
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2024
Figure 3: G8 pharmaceuticals industry, revenue by country ($m), 2020-24
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($m), 2024-29
Figure 5: Canada pharmaceuticals market value: $ million, 2019-24
Figure 6: Canada pharmaceuticals market category segmentation: $ million, 2019-24
Figure 7: Canada pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 8: Canada pharmaceuticals market value forecast: $ million, 2024-29
Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2024
Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2024
Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2024
Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2024
Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2024
Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2024
Figure 15: France pharmaceuticals market value: $ million, 2019-24
Figure 16: France pharmaceuticals market category segmentation: $ million, 2019-24
Figure 17: France pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 18: France pharmaceuticals market value forecast: $ million, 2024-29
Figure 19: Forces driving competition in the pharmaceuticals market in France, 2024
Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2024
Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2024
Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2024
Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2024
Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2024
Figure 25: Germany pharmaceuticals market value: $ million, 2019-24
Figure 26: Germany pharmaceuticals market category segmentation: $ million, 2019-24
Figure 27: Germany pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 28: Germany pharmaceuticals market value forecast: $ million, 2024-29
Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2024
Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2024
Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2024
Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2024
Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2024
Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2024
Figure 35: Italy pharmaceuticals market value: $ million, 2019-24
Figure 36: Italy pharmaceuticals market category segmentation: $ million, 2019-24
Figure 37: Italy pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 38: Italy pharmaceuticals market value forecast: $ million, 2024-29
Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2024
Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2024
Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2024
Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2024
Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2024
Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2024
Figure 45: Japan pharmaceuticals market value: $ million, 2019-24
Figure 46: Japan pharmaceuticals market category segmentation: $ million, 2019-24
Figure 47: Japan pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 48: Japan pharmaceuticals market value forecast: $ million, 2024-29
Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2024
Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2024
Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2024
Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2024
Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2024
Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2024
Figure 55: Russia pharmaceuticals market value: $ million, 2019-24
Figure 56: Russia pharmaceuticals market category segmentation: $ million, 2019-24
Figure 57: Russia pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 58: Russia pharmaceuticals market value forecast: $ million, 2024-29
Figure 59: Forces driving competition in the pharmaceuticals market in Russia, 2024
Figure 60: Drivers of buyer power in the pharmaceuticals market in Russia, 2024
Figure 61: Drivers of supplier power in the pharmaceuticals market in Russia, 2024
Figure 62: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2024
Figure 63: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2024
Figure 64: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2024
Figure 65: United Kingdom pharmaceuticals market value: $ million, 2019-24
Figure 66: United Kingdom pharmaceuticals market category segmentation: $ million, 2019-24
Figure 67: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 68: United Kingdom pharmaceuticals market value forecast: $ million, 2024-29
Figure 69: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2024
Figure 70: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2024
Figure 71: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2024
Figure 72: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2024
Figure 73: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2024
Figure 74: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2024
Figure 75: United States pharmaceuticals market value: $ million, 2019-24
Figure 76: United States pharmaceuticals market category segmentation: $ million, 2019-24
Figure 77: United States pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 78: United States pharmaceuticals market value forecast: $ million, 2024-29
Figure 79: Forces driving competition in the pharmaceuticals market in the United States, 2024
Figure 80: Drivers of buyer power in the pharmaceuticals market in the United States, 2024
Figure 81: Drivers of supplier power in the pharmaceuticals market in the United States, 2024
Figure 82: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2024
Figure 83: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2024
Figure 84: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2024

$1,495.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports